Silver Book Fact

The number of cases of visual impairment and blindness from age-related macular degeneration (AMD0 is projected to increase from 620,000 in 2010 to 1.6 million in 2050–assuming no treatments.

Rein, David. B., John S. Wittenborn, Xinzhi Zhang, Amanda A. Honeycutt, Sarah B. Lessene, and Jinan Saadine; for the Vision Health Cost-Effectiveness Study Group. Forecasting Age-Related Macular Degeneration Through the Year 2050. Arch Ophthalmol. 2009; 127(4): 533-40. http://jama.ama-assn.org/content/301/20/2152.extract

Reference

Title
Forecasting Age-Related Macular Degeneration Through the Year 2050
Publication
Arch Ophthalmol
Publication Date
2009
Authors
Rein, David. B., John S. Wittenborn, Xinzhi Zhang, Amanda A. Honeycutt, Sarah B. Lessene, and Jinan Saadine; for the Vision Health Cost-Effectiveness Study Group
Volume & Issue
Volume 127, Issue 4
Pages
533-40
URL
Read Full Resource

Categories

  • Cost of Disease
  • Future Human Burden

Related Facts

  • Global DR Prevalence
    The overall prevalence of global DR is 34.6%—6.96% for PDR, 6.81% for DME, and 10.2% for vision-threatening DR.  
  • Around $62 million a year is spent on guide dogs for individuals 40 years and older with visual impairment (in 2004 dollars).  
  • Future Impact of DR
    The rise of DR will disproportionately impacting the poorest populations, since 80% of people with diabetes live in low-middle income countries.  
  • In one study, individuals age 80 and older made up 8% of the population, yet accounted for 69% of cases of blindness.  
  • More than 7.6 million Americans age 40 and older have diabetic retinopathy—7,685,237.